Effects of the 5-HT1C/5-HT2 receptor agonists DOI and α-methyl-5-HT on plasma glucose and insulin levels in the rat
- 1 October 1990
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 187 (3) , 435-443
- https://doi.org/10.1016/0014-2999(90)90370-l
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Ganglionic transmission is a prerequisite for the adrenaline-releasing and hyperglycemic effects of 8-OH-DPATEuropean Journal of Pharmacology, 1990
- Nervous regulation of metabolismProgress in Neurobiology, 1989
- The differential effects of prazosin and hydralazine on sympathoadrenal activity in conscious ratsEuropean Journal of Pharmacology, 1989
- Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOIEuropean Journal of Pharmacology, 1989
- Evidence that the novel antihypertensive agent, flesinoxan, causes differential sympathoinhibition and also increases vagal tone by a central actionEuropean Journal of Pharmacology, 1988
- Molecular pharmacology and biology of 5-HT1C receptorsTrends in Pharmacological Sciences, 1988
- Central serotonin receptors as targets for drug researchJournal of Medicinal Chemistry, 1987
- 5-HT-la and 5-HT-lb selectivity of two phenylpiperazine derivatives: Evidence for 5-HT-lb heterogeneityLife Sciences, 1985
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Studies on the hyperglycemia and hepatic glycogenolysis produced by alpha and beta adrenergic agonists in the catLife Sciences, 1980